Alessandra Cicia

Rome, 00168, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Dynamics of Myelin-Specific T-Cell Repertoires Mirror Disease Activity and Central Nervous System Trafficking in Multiple Sclerosis.

Dynamics of Myelin-Specific T-Cell Repertoires Mirror Disease Activity and Central Nervous System Trafficking in Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: June 17, 2026

Immune-mediated necrotizing myopathies: clinico-serological features and treatment outcomes of a large Italian cohort of patients.

Immune-mediated necrotizing myopathies: clinico-serological features and treatment outcomes of a large Italian cohort of patients.

Journal: Journal of neurology

Published: May 04, 2026

Childhood trauma and treatment compliance in people with multiple sclerosis: The mediating role of physician-patient rapport.

Childhood trauma and treatment compliance in people with multiple sclerosis: The mediating role of physician-patient rapport.

Journal: Multiple sclerosis and related disorders

Published: March 05, 2026

IgE-mediated allergic reactions to ocrelizumab in multiple sclerosis: A retrospective cohort study.

IgE-mediated allergic reactions to ocrelizumab in multiple sclerosis: A retrospective cohort study.

Journal: Multiple sclerosis and related disorders

Published: July 17, 2025

Muscle Imaging in Inclusion Body Myositis: Refinement of MRI Criteria and Insights Into Upper Body Involvement.

Muscle Imaging in Inclusion Body Myositis: Refinement of MRI Criteria and Insights Into Upper Body Involvement.

Journal: Journal of cachexia, sarcopenia and muscle

Published: July 11, 2025

Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice.

Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice.

Journal: Therapeutic advances in neurological disorders

Published: July 10, 2025

Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty.

Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty.

Journal: Neurology and therapy

Published: May 25, 2025

Paramagnetic Rim Lesions in Highly Active Multiple Sclerosis at the Time of Disease Diagnosis: Prevalence Data and Clinical Implications.

Paramagnetic Rim Lesions in Highly Active Multiple Sclerosis at the Time of Disease Diagnosis: Prevalence Data and Clinical Implications.

Journal: European journal of neurology

Published: May 17, 2025

Wash-out duration and lymphocyte count in switching from fingolimod to ofatumumab: A case report and literature review.

Wash-out duration and lymphocyte count in switching from fingolimod to ofatumumab: A case report and literature review.

Journal: Journal of neuroimmunology

Published: November 24, 2024

Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant?

Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant?

Journal: International journal of molecular sciences

Published: March 17, 2024

Tumefactive Demyelinating Lesion Around a Developmental Venous Anomaly : A Rare Association.

Tumefactive Demyelinating Lesion Around a Developmental Venous Anomaly : A Rare Association.

Journal: Clinical neuroradiology

Published: April 24, 2023

New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report.

New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report.

Journal: Journal of neurology

Published: August 30, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026